
Silvia Novello
Articles
-
Feb 29, 2024 |
thelancet.com | Umberto Malapelle |Silvia Novello
In the era of precision oncology, a rapidly increasing number of predictive biomarkers have been routinely implemented to define the advanced non-small cell lung cancer (NSCLC) patients’ treatment decision making process.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →